Issue 150 • January 2025

US reproductive laws could limit women’s participation in clinical trials

Uncertainty after the US Supreme Court decision to severely limit abortion access has been heightened following Donald Trump’s election win

Briefing

New study finds obesity costs US industry $347bn a year

Feature

How Pfizer management outplayed activist investor Starboard

Comment

Lilly’s £279m bet aims to boost UK life sciences sector

In Data

Leading innovators in aircraft air conditioning

Pharma Event Guide

The year ahead in pharma

Go to article: Home | US reproductive laws could limit women’s participation in clinical trialsGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: Avenga Company InsightGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: InterphexGo to article: Investment and Development Agency of Latvia Company InsightGo to article: In DepthGo to article: US reproductive laws could limit women’s participation in clinical trialsGo to article: How Pfizer management outplayed activist investor StarboardGo to article: Trump 2.0 spells global change in pharmaceutical regulation, funding and investmentGo to article: Flu vaccine strategy on the line as new US leaders anticipated to take chargeGo to article: Lilly’s £279m bet aims to boost UK life sciences sectorGo to article: PrEP therapies offer new hope in HIV preventive landscape as vaccine failures amassGo to article: DatwylerGo to article: Pharma Event GuideGo to article: In this guideGo to article: Avenga Company InsightGo to article: AST Company InsightGo to article: ICROM Company InsightGo to article: Girteka Company InsightGo to article: 2024 Event HighlightsGo to article: Swiss biotech ecosystem recuperates from global financial instabilityGo to article: Cell and gene therapy approvals drive paradigm change in manufacturingGo to article: Will the tide turn for the wave of pharma layoffs?Go to article: AIDS 24: Prioritise at risk populations for trials, testing and treatmentGo to article: Pharma readies for climate disasters amidst supply chain concernsGo to article: Amgen showcases exciting potential in the obesity space at JPM24 Go to article: Experts call for a shift from reactive to proactive clinical trial supply frameworksGo to article: 2025 Event CalendarGo to article: InterphexGo to article: Advertise with usGo to article: ListingsGo to article: Pharmaceutical Technology Excellence Awards 2024 winnersGo to article: Buyer's GuidesGo to article: Next issue